Successful extracorporeal membrane oxygenation–bridged rituximab desensitization enabling blood type–incompatible living-donor lung transplantation

JTCVS Techniques 2026 Open access

Read full text
Authors: Yui Watanabe, Takashi Hirama, Tatsuaki Watanabe, Hisashi Oishi, Miki Akiba, Shunta Mukai, Mikako Saito, Sakiko Kumata, Ken Onodera, Takeo Togo, Hirotsugu Notsuda, Takaya Suzuki
+2 more Hiromichi Niikawa, Yoshinori Okada
DOI: 10.1016/j.xjtc.2026.102287
Cited by: 0
References: 8

Abstract

Living-donor lobar lung transplantation (LDLLT) offers a life-saving option for patients with rapidly progressive respiratory failure when deceased-donor allocation cannot meet urgent needs.1,E1 Although ABO-incompatible (ABO-i) transplantation is well established in kidneyE2 and liverE3,E4 transplantation, its application in lung transplantation remains uncommon and recently explored.2

Fields of Study & Subjects

Transplantation: Methods and Outcomes Organ Donation and Transplantation Mechanical Circulatory Support Devices

Publication details

Journal / source
JTCVS Techniques
Volume
36
Pages
102287–102287
Publication date
18 February 2026
Language
EN